Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: Pooled analysis of three double-blind, randomized, crossover, multicenter studies

Neurological Sciences

Volumn 33, Issue SUPPL. 1, 2012, Pages

  Allais, Gianni ^a   Tullo, Vincenzo ^b   Omboni, Stefano ^c   Benedetto, Chiara ^a   Sances, Grazia ^d   Zava, Dario ^e   Ferrari, Michel D ^f   Bussone, Gennaro ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c ITALIAN INSTITUTE OF TELEMEDICINE   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^e Istituto Lusofarmaco d'Italia   (Italy)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Almotriptan; Frovatriptan; Menstrually related migraine; Rizatriptan; Zolmitriptan

Indexed keywords

ALMOTRIPTAN; FROVATRIPTAN; RIZATRIPTAN; ZOLMITRIPTAN;

ADULT; ANALGESIA; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MENSTRUAL MIGRAINE; MULTICENTER STUDY (TOPIC); PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; UNSPECIFIED SIDE EFFECT;

ADULT; CARBAZOLES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ITALY; MALE; MENSTRUAL CYCLE; MIDDLE AGED; MIGRAINE WITH AURA; SEROTONIN RECEPTOR AGONISTS; TIME FACTORS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 84864275291     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1044-7     Document Type: Conference Paper

References (19)

1. Loder E (2001) Menstrual migraine. Curr Treat Options Neurol 3:189-200
2. Martin VT, Lipton RB (2008) Epidemiology and biology of menstrual migraine. Headache 48(Suppl 3):S124-S130
3. Taylor FR (2009) Clinical aspects of perimenstrual headaches. Curr Pain Headache Rep 13:75-81
4. Mannix LK, Files JA (2005) The use of triptans in the management of menstrual migraine. CNS Drugs 19:951-972 (Pubitemid 41573611)
5. MacGregor EA (2010) Prevention and treatment of menstrual migraine. Drugs 70:1799-1818
6. Pringsheim T, Davenport WJ, Dodick D (2008) Acute treatment and prevention of menstrually related migraine headache: evidence- based review. Neurology 70:1555-1563 (Pubitemid 351589510)
7. Markus F, Mikko K (2007) Frovatriptan review. Expert Opin Pharmacother 8:3029-3033 (Pubitemid 350285016)
8. Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L (2011) Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, crossover, multicenter, Italian, comparative study versus rizatriptan. J Headache Pain 12:609-615
9. Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G (2011) Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan. Neurol Sci 32(Suppl 1):S99-S104
10. Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Fierro B (2012) Frovatriptan vs. almotriptan for acute treatment of perimenstrual migraine: analysis of a double-blind, randomized, crossover, multicenter, Italian, comparative study. J Headache Pain (submitted)
11. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9-160
12. Loder E (2010) Triptan therapy in migraine. N Engl J Med 363:63-70
13. Allais G, Acuto G, Cabarrocas X, Esbri R, Benedetto C, Bussone G (2006) Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 27(Suppl 2):S193-S197 (Pubitemid 44390141)
14. Poolsup N, Leelasangaluk V, Jittangtrong J, Rithlamlert C, Ratanapantamanee N, Khanthong M (2005) Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials. J Clin Pharm Ther 30:521-532 (Pubitemid 43960978)
15. Cady RK, Banks J, Jones BA, Campbell J (2009) Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination. Curr Med Res Opin 25:2711-2721
16. Wallasch TM (2010) Frovatriptan in the practice of office-based neurologists/pain therapists: results of postmarketing surveillance study ALADIN. Adv Ther 27:56-62
17. Kelman L, Harper SQ, Hu X, Campbell JC (2010) Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline. Curr Med Res Opin 26:2097-2104
18. Géraud G, Spierings EL, Keywood C (2002) Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache 42(Suppl 2):S93-S99 (Pubitemid 34568922)
19. MacGregor EA, Pawsey SP, Campbell JC, Hu X (2010) Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: results of a new analysis of data from five previously published studies. Gend Med 7:88-108